HUP0302020A2 - 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives, process for their preparation and pharmaceutical compositions containing the same - Google Patents
2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives, process for their preparation and pharmaceutical compositions containing the sameInfo
- Publication number
- HUP0302020A2 HUP0302020A2 HU0302020A HUP0302020A HUP0302020A2 HU P0302020 A2 HUP0302020 A2 HU P0302020A2 HU 0302020 A HU0302020 A HU 0302020A HU P0302020 A HUP0302020 A HU P0302020A HU P0302020 A2 HUP0302020 A2 HU P0302020A2
- Authority
- HU
- Hungary
- Prior art keywords
- triene
- chola
- derivatives
- substituted
- preparation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 229930182558 Sterol Natural products 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 1
- 230000002456 anti-arthritic effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003509 anti-fertility effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002402 anti-lipaemic effect Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000002682 anti-psoriatic effect Effects 0.000 abstract 1
- 230000003356 anti-rheumatic effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- -1 nootropic Substances 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 150000003432 sterols Chemical class 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 150000005671 trienes Chemical class 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Steroid Compounds (AREA)
Abstract
2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10) triene derivatives (I) are new. Sterol derivatives of formula (I) are new. [Image] R1>H or an O-protecting group; R2>OH, lower alkoxy, carboxaldehyde, lower alk-1-enyl or lower alkyl substituted by OH or lower alkoxy; R3>Me in the alpha or beta configuration; X : a bond or 1-3 alkylene; Y : a carboxaldehyde group or C(R4>)(R5>)OR1>; R4>,R5>H, alkyl, alkenyl or alkynyl with the proviso that the total C content or R4> and R5> does not exceed 3 atoms and the further proviso that X is a valence bond when both R4> and R5> are other than H; and the dotted line signifies an optional double bond. ACTIVITY : Cytostatic, antiproliferative, vulnerary, immunosuppressive, antiinflammatory, osteopathic, dermatological, hypotensive, antirheumatic, antiarthritic, antipsoriatic, antiasthmatic, nootropic, contraceptive, antilipemic, antiangiogenic, anticoagulant, antiseborrheic, neuroprotective; antifertility. MECHANISM OF ACTION : (I) are estrogen response modulators.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20346300P | 2000-05-11 | 2000-05-11 | |
PCT/GB2001/002103 WO2001085755A1 (en) | 2000-05-11 | 2001-05-11 | 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0302020A2 true HUP0302020A2 (en) | 2003-09-29 |
Family
ID=28454336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302020A HUP0302020A2 (en) | 2000-05-11 | 2001-05-11 | 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives, process for their preparation and pharmaceutical compositions containing the same |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP0302020A2 (en) |
-
2001
- 2001-05-11 HU HU0302020A patent/HUP0302020A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508868A (en) | Pharmaceutical preparations containing esters 1,3,5, (10) -trien and pharmaceutical preparation | |
Wiechert et al. | Synthesis of antiprogestational steroids | |
EP1148062A3 (en) | Sterol compositions from pulping soap | |
IL104105A0 (en) | New 19-nor steroids having a thiocarbon chain in position 11-beta,their preparation process and pharmaceutical compositions containing them | |
US4248791A (en) | 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol | |
IL72067A (en) | 1-alkyl-androsta-1,4-diene-3,17-diones,processes for their preparation and pharmaceutical compositions containing the same | |
PT79839A (en) | Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith | |
KR890006667A (en) | Androstane 17-carboxylic acid ester, preparation method thereof, and pharmaceutical agent containing same | |
HUP0302020A2 (en) | 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives, process for their preparation and pharmaceutical compositions containing the same | |
AU659118B2 (en) | 14beta-H-, 14- and 15-EN-11beta -aryl-4-estrenes | |
AU580086B2 (en) | New steroids substituted at position 10 by a radical including a double or triple bond, their preparation process, their use as medicaments, pharmaceutical compositions containing them | |
EP0712412B1 (en) | 15,15-dialkyl-substituted derivatives of estradiol | |
DE3776572D1 (en) | 14,17-G (B) -ETHANO-14-G (B) -ESTRATRIENE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
DE69318474T2 (en) | New (estradiol derivative) chlorambucil conjugates, process for their preparation and pharmaceutical preparations | |
EP1226155A2 (en) | 18-nor-steroids as selectively active estrogens | |
IT1154735B (en) | AMINO-14 STEROID DERIVATIVES AND PROCEDURE FOR THEIR PREPARATION | |
ZA924665B (en) | Substituted 16-methyl steroid derivatives of pregna-1, 4-dien-3,20-doine, their preparation, their use in the preparation of 16-methylene steroids and intermediates. | |
PL361666A1 (en) | 17alpha fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds | |
WO2001053321A3 (en) | Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers | |
DE59108246D1 (en) | UNSATURATED 15-DEHYDRO-17alpha-CYANOMETHYL-17beta- HYDROXYSTEROIDS | |
AR010857A1 (en) | SUBSTITUTED STEROIDS IN POSITION 11, THEIR PREPARATION PROCEDURE, THEIR APPLICATION AS A MEDICINAL PRODUCT AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
EP0707593B1 (en) | Orally administerable esters of 14 alpha,15 alpha-methylene-oestradiol with an oestrogenic action | |
GB1145063A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
DE69306513T2 (en) | New cardioactive cyclopentaperhydrophenanthrene-17-beta (hydroxy or alkoxy) -17-alpha- (aryl or heterocyclic) -3-beta derivatives, a process for their preparation and pharmaceutical preparations thereof | |
ATE31066T1 (en) | 15,16-METHYLENE-17-ALPHA-PREGNA-4,6-DIENINE-21CARBONS|URESALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESSES FOR THEIR MANUFACTURE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |